Clinical Site Partners

Leesburg, Florida 34748

0 studies enrolling now · 3 studies all time

What they study most

COVID-19 Disease, Celiac Disease, Refractory Chronic Cough

Studies at this site

• ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2 — Completed
• Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients — Completed
• Placebo-controlled, Single and Multiple Dose Study in Healthy Volunteers and Refractory Chronic Cough Patients to Assess the Safety, Tolerability, and Pharmacokinetics of Two Formulations of NTX-1175 — Completed